24/7 Wall Street
30 Jun 2026, 13:50 UTC · 3h ago
This 7% Yielding Healthcare Powerhouse Belongs in Retirees' Portfolios
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
24/7 Wall Street
30 Jun 2026, 13:50 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Pfizer's free cash flow in 2025 was $9.08 billion, failing to cover the $9.77 billion paid out in dividends. — A dividend payout ratio above 100% of free cash flow suggests the dividend is unsustainable without borrowing or asset sales.
-0.60Eleven Pfizer directors acquired phantom stock at $26.67 on a single day, and CEO Albert Bourla purchased shares six times within three months. — Significant coordinated insider buying typically signals management's confidence that the current share price is undervalued.
+0.50Pfizer's net debt-to-EBITDA has risen to 3.26x following the Seagen acquisition. — Elevated leverage increases financial risk and puts pressure on the company to meet cost-saving targets to maintain its credit profile.
-0.30Continue reading
6 related stories
Search tags
The company has set a $7.2 billion cost savings target by the end of 2027 to protect its dividend payout. — Successful execution of cost-cutting measures would improve margins and secure the yield for income investors.
+0.20COVID-19 franchise revenues saw sharp declines in Q1 2026, with Comirnaty down 59% and Paxlovid down 63%. — This confirms the continued erosion of the pandemic-era revenue surge, forcing the company to rely on its non-COVID portfolio.
-0.20Which stocks this story touches
Described as a cash-generating utility for corporate AI orchestration.
Mentioned as a highly successful stock call by a renowned analyst.
Despite COVID revenue erosion and FCF shortfalls, the dividend is rated as safe and insider buying is strong.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
24/7 Wall Street
1h ago
